Whilst these findings of increased ADAR1 levels and activity in cancer and the genetic sensitivity of subsets of cancer to loss of ADAR1 have been broadly supported, the role of elevated ADAR1 in tumor initiation and progression have only been tested in limited settings. The gene discussed is ADAR; the disease is neoplasm.